Source link : https://www.newshealth.biz/health-news/rifaximin-reduced-overt-hepatic-encephalopathy-recurrence-over-lactulose/
Roughly half as many patients with cirrhosis in remission from overt hepatic encephalopathy (OHE) experienced a breakthrough episode with rifaximin monotherapy compared with lactulose monotherapy, a post-hoc analysis of two randomized trials showed. Over 6 months, 23.2% of patients receiving rifaximin monotherapy experienced an OHE breakthrough episode compared with 49% of patients receiving lactulose monotherapy […]
Author : News Health
Publish date : 2024-11-01 15:16:15
Copyright for syndicated content belongs to the linked Source.